Newsletter.exe
Willy Braun, Kevin KuipersA monthly inside look at emerging technologies, innovation funding, and the real work of early-stage venture capital.
| Platform |  | Pricing | Only free issues | Publishes | Monthly |
|---|---|---|---|---|---|
| Issues | 8 | Founded | a year ago | Last Issue | 4 months ago |
| Active | |||||
Read this Newsletter
newsletterexe.substack.comLatest Issues
Newsletter.exe - January 2026
Heads up: this newsletter is deliberately long-form and will be truncated in your inbox. To read the full version, click "View entire message" or open it directly in your browser by clicking the title above. This letter was originally writt...
Newsletter.exe - December 2025
Heads up: this newsletter is deliberately long-form and will be truncated in your inbox. To read the full version, click "View entire message" or open it directly in your browser by clicking the title above. This letter was originally writt...
Newsletter.exe - November 2025
Heads up: this newsletter is deliberately long-form and may be truncated in your inbox. To read the full version, click "View entire message" or open it directly in your browser by clicking the title above. This letter was originally writte...
Newsletter.exe - September 2025
Heads up: this newsletter is deliberately long-form and may be truncated in your inbox. To read the full version, click "View entire message" or open it directly in your browser by clicking the title above. This letter was originally writte...
Newsletter.exe - June 2025
Heads up: this newsletter is deliberately long-form and may be truncated in your inbox. To read the full version, click "View entire message" or open it directly in your browser by clicking the title above. This letter was originally writte...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Newsletter.exe.
| Subscribers | Engagement | 59 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Founding Parter Galion.exe / Prev: co-founder Daphni & France Digitale VC who ❤️ books & social sciences \ud83d\udc49 libido-sciendi.com
Co-Founder & Partner @ Galion.exe, TTY. Also co-founded Gamekult.com, SensCritique, Molotov.tv
Frequently Asked Questions
How can I access the email archive for Newsletter.exe?
You can find recent issues that have been published by Newsletter.exe on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Newsletter.exe have?
To see how many people subscribe to Newsletter.exe, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Newsletter.exe?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Newsletter.exe as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Newsletter.exe?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Newsletter.exe using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Newsletter.exe?
Scroll up to where it says Related Newsletters to see other publications like Newsletter.exe. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Newsletter.exe?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.